Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3NU9

Crystal Structure of HIV-1 Protease Mutant I84V with Antiviral Drug Amprenavir

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsAPS BEAMLINE 22-ID
Synchrotron siteAPS
Beamline22-ID
Temperature [K]100
Detector technologyCCD
Collection date2008-03-28
DetectorMARMOSAIC 300 mm CCD
Wavelength(s)1.0000
Spacegroup nameP 21 21 2
Unit cell lengths59.513, 86.881, 45.448
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution9.970 - 1.850
R-factor0.20066
Rwork0.199
R-free0.23555
Structure solution methodMOLECULAR REPLACEMENT
Starting model (for MR)2f8g
RMSD bond length0.014
RMSD bond angle1.546
Data reduction softwareHKL-2000
Data scaling softwareHKL-2000
Phasing softwareMOLREP
Refinement softwareREFMAC (5.2.0019)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]50.0001.900
High resolution limit [Å]1.8501.850
Rmerge0.0970.345
<I/σ(I)>2.7
Completeness [%]93.276.6
Redundancy43.6
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, HANGING DROP4298Crystal was grown by the hanging-drop vapor-diffusion method at room temperature, from a 2.2 mg/ml protein solution at pH 4.0 with 0.13M NaI, 0.1M NaOAc. The inhibitor was mixed with protease in a ratio 5:1 , VAPOR DIFFUSION, HANGING DROP, temperature 298K

219869

PDB entries from 2024-05-15

PDB statisticsPDBj update infoContact PDBjnumon